willow health glp 1 Start (@startwillow) • Instagram photos and videos Willow's 90-Day GLP-1 Program: A

The lack of reimbursement has led to disparities in access to care

Every plan sponsor and PBM are now recalculating 2027 formulary strategies

Strong weight loss outcomes at lower doses are both achievable and well established in the literature

Originally developed for type 2 diabetes, GLP-1 receptor agonists, like semaglutide, work by stimulating insulin release, slowing digestion, and signaling fullness in the brain

Patients should be advised of the potential for experiencing GI adverse effects after switching to a different GLP-1 receptor agonist and that (as with the initiation of the prior GLP-1 receptor agonist) they should expect these effects to improve over time

Beckwith, W